# ![@_NathanLambert_ Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1206869512236220417.png) @_NathanLambert_ Nathan Lambert

Nathan Lambert posts on X about $srpt, is there, stack, shorts the most. They currently have [--] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: undefined [#](/creator/twitter::1206869512236220417/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1206869512236220417/c:line/m:interactions.svg)

- [--] Week [---] -33%
- [--] Month [---] +60,800%
- [--] Months [---] +105%

### Mentions: undefined [#](/creator/twitter::1206869512236220417/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1206869512236220417/c:line/m:posts_active.svg)

- [--] Week [--] +100%
- [--] Month [--] +200%
- [--] Months [--] +200%

### Followers: [--] [#](/creator/twitter::1206869512236220417/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1206869512236220417/c:line/m:followers.svg)

- [--] Week [--] -9.10%
- [--] Month [--] no change
- [--] Months [--] no change

### CreatorRank: [---------] [#](/creator/twitter::1206869512236220417/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1206869512236220417/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance) 

**Social topic influence**
[$srpt](/topic/$srpt), [is there](/topic/is-there), [stack](/topic/stack), [shorts](/topic/shorts), [financial](/topic/financial)

**Top accounts mentioned or mentioned by**
[@marksharkking](/creator/undefined) [@aimatmelanoma](/creator/undefined) [@thackerpd](/creator/undefined) [@watcherguru](/creator/undefined) [@aistocksavvy](/creator/undefined)

**Top assets mentioned**
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt)
### Top Social Posts
Top posts by engagements in the last [--] hours

"A bear market is the best time to build wealth"  
[X Link](https://x.com/_NathanLambert_/status/1916307560560529873)  2025-04-27T01:45Z [--] followers, [--] engagements


"@MarkSharkKing I remember $SRPT already got the label expansion from the FDA back in June [----]. That's why. now elevidys is approved for all patients aged 4+ whether theyre walking or not"  
[X Link](https://x.com/_NathanLambert_/status/1932801449932513380)  2025-06-11T14:05Z [--] followers, [---] engagements


"@AIMatMelanoma This is heartbreaking. Families facing stage [--] melanoma deserve every possible option not to have their hope taken away. Denying Replimune is like denying them the chance to fight back the cancer. It should be approved so families like them are not left with out options"  
[X Link](https://x.com/_NathanLambert_/status/1963266251783889307)  2025-09-03T15:42Z [--] followers, [---] engagements


"@thackerpd What a joke study design issues. How did they even come to that conclusion And about your claim that Replimune is bribing STAT is there any proof Instead of spreading baseless accusations we should be focusing on the patients who need these treatments"  
[X Link](https://x.com/_NathanLambert_/status/1963609701867753805)  2025-09-04T14:26Z [--] followers, [---] engagements


"@WatcherGuru This is what approval looks like in 2026: quiet review loud rumors then purchase orders. The real risk isnt demand its drawn-out uncertainty that pushes customers to redesign around a different stack"  
[X Link](https://x.com/_NathanLambert_/status/2010291344166531259)  2026-01-11T10:03Z [--] followers, [--] engagements


"Rebalancing your portfolio once a year is plenty"  
[X Link](https://x.com/_NathanLambert_/status/2014957697079161198)  2026-01-24T07:05Z [--] followers, [--] engagements


"@AIStockSavvy This is the pivot people have been waiting for. While the shorts are still obsessing over the DMD cycle $SRPT is quietly scaling its siRNA platform into a multi-billion dollar CNS market. Between this and the 3-year EMBARK wins the 'one-trick pony' narrative is officially dead"  
[X Link](https://x.com/_NathanLambert_/status/2019823150545138095)  2026-02-06T17:19Z [--] followers, [---] engagements


"Sarepta Therapeutics to announce fourth quarter and full-year [----] financial results #SareptaTherapeutics $SRPT #earningscall https://www.marketscreener.com/news/sarepta-therapeutics-to-announce-fourth-quarter-and-full-year-2025-financial-results-ce7e5addd189f024 https://www.marketscreener.com/news/sarepta-therapeutics-to-announce-fourth-quarter-and-full-year-2025-financial-results-ce7e5addd189f024"  
[X Link](https://x.com/_NathanLambert_/status/2022181188140413252)  2026-02-13T05:29Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing